Completed Genetics & Molecular Biology Infection & Immunity

Molecular mechanisms mediating immune evasion in African trypanosomes

In plain English

AI plain-English summary

A single-celled parasite switches off its protective protein coat at the wrong time, and its own cell cycle slams on the brakes, killing it before it can divide. The African trypanosome, *Trypanosoma brucei*, causes sleeping sickness in humans and nagana in livestock. It survives by covering itself in a dense coat of a single protein, VSG, and by expressing only one VSG gene at a time from dozens of possible sites. This project asks how the parasite enforces that strict one-gene-only rule, and what happens when the rule breaks. The researchers have already created strains that flicker between two VSG coats, and have discovered that blocking a routine RNA processing step shuts down VSG production entirely. This is fundamental science. It asks how an unusual gene expression system works in a pathogen that has evolved to outrun the mammalian immune system. If the researchers identify the molecular switches that enforce mono-allelic exclusion or the sensor that triggers cell-cycle arrest, those switches become potential drug targets. A compound that mimics the arrest signal, for example, could force the parasite to stop dividing without ever needing to attack its coat. Past work on trypanosome gene expression has already revealed unexpected mechanisms—such as RNA editing—that later became targets for drug development.

View original technical description
The African trypanosome Trypanosoma brucei is an extraordinarily effective extracellular pathogen. Key for its survival is a protective Variant Surface Glycoprotein (VSG) coat, which is expressed at an extraordinarily high level from a VSG gene located in an RNA polymerase I transcribed VSG expression site. Although an individual trypanosome has multiple bloodstream form expression sites, stringent mono-allelic exclusion ensures that only one is transcribed at a time. We would like to understand how this mono-allelic exclusion operates. We have generated T. brucei strains with disrupted mono-allelic exclusion, which dynamically switch between two different expression sites. What restriction has disappeared? T. brucei additionally contains metacyclic expression sites, which are mono-allelically expressed in the relevant life-cycle stage. How are these different types of expression sites controlled? We have recently made the striking discovery that blocking trans-splicing leads to an abrupt halt in transcription of the active VSG expression site. How does RNA processing feed back to control this unusual RNA polymerase I transcription unit? Last, we have discovered that VSG synthesis is sensed during the cell cycle, and blocking its synthesis triggers a precise pre-cytokinesis cell cycle arrest. How does this happen, and what stress responses are triggered?

View the original record at the funder ↗

Researchers

Gloria Rudenko (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Molecular mechanisms mediating immune evasion in African trypanosomes.
Investigation of control of Variant Surface Glycoprotein gene expression sites in the African trypanosome Trypanosoma brucei
Decoding mechanisms of gene regulation in African trypanosomes
Dissecting the molecular basis of single gene choice in African trypanosomes
Telomeric chromatin and VSG allelic exclusion in African trypanosomes

Original classification

Senior Research Fellowship Basic Renewal

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.